vs
Side-by-side financial comparison of LifeStance Health Group, Inc. (LFST) and RISKIFIED LTD. (RSKD). Click either name above to swap in a different company.
LifeStance Health Group, Inc. is the larger business by last-quarter revenue ($382.2M vs $234.0M, roughly 1.6× RISKIFIED LTD.). LifeStance Health Group, Inc. runs the higher net margin — 3.1% vs -13.2%, a 16.2% gap on every dollar of revenue.
Lifestance Health (Lifestance) is an American outpatient behavioral health services provider. They provide their services in person and via tele-health. Their services include therapy, psychiatry, TMS, and ketamine therapies. They have landed in lawsuits multiple times over labor violations, leaking of customer information, and misleading investors.
Riskified is a publicly traded software company headquartered in Tel Aviv, Israel, with additional offices in New York City. The company provides software-as-a-service (SaaS) solutions focused on fraud prevention, chargeback management, and risk intelligence for e-commerce merchants.
LFST vs RSKD — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $382.2M | $234.0M |
| Net Profit | $11.7M | $-30.8M |
| Gross Margin | — | 52.2% |
| Operating Margin | 4.7% | -19.0% |
| Net Margin | 3.1% | -13.2% |
| Revenue YoY | 17.4% | — |
| Net Profit YoY | 264.1% | — |
| EPS (diluted) | — | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $382.2M | — | ||
| Q3 25 | $363.8M | $234.0M | ||
| Q2 25 | $345.3M | $155.1M | ||
| Q1 25 | $333.0M | $76.4M | ||
| Q4 24 | $325.5M | — | ||
| Q3 24 | $312.7M | $213.5M | ||
| Q2 24 | $312.3M | $141.7M | ||
| Q1 24 | $300.4M | $68.9M |
| Q4 25 | $11.7M | — | ||
| Q3 25 | $1.1M | $-30.8M | ||
| Q2 25 | $-3.8M | $-21.1M | ||
| Q1 25 | $709.0K | $-11.6M | ||
| Q4 24 | $-7.1M | — | ||
| Q3 24 | $-6.0M | $-55.8M | ||
| Q2 24 | $-23.3M | $-34.8M | ||
| Q1 24 | $-21.1M | $-18.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | 52.2% | ||
| Q2 25 | — | 53.6% | ||
| Q1 25 | — | 55.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 48.7% | ||
| Q2 24 | — | 51.4% | ||
| Q1 24 | — | 52.0% |
| Q4 25 | 4.7% | — | ||
| Q3 25 | 2.0% | -19.0% | ||
| Q2 25 | -0.9% | -19.4% | ||
| Q1 25 | 0.5% | -20.8% | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.0% | -32.9% | ||
| Q2 24 | -5.1% | -31.8% | ||
| Q1 24 | -5.6% | -33.4% |
| Q4 25 | 3.1% | — | ||
| Q3 25 | 0.3% | -13.2% | ||
| Q2 25 | -1.1% | -13.6% | ||
| Q1 25 | 0.2% | -15.2% | ||
| Q4 24 | -2.2% | — | ||
| Q3 24 | -1.9% | -26.1% | ||
| Q2 24 | -7.5% | -24.6% | ||
| Q1 24 | -7.0% | -26.1% |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $248.6M | $371.1M |
| Total DebtLower is stronger | $282.8M | — |
| Stockholders' EquityBook value | $1.5B | $382.3M |
| Total Assets | $2.2B | $495.9M |
| Debt / EquityLower = less leverage | 0.19× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $248.6M | — | ||
| Q3 25 | $203.9M | $371.1M | ||
| Q2 25 | $188.9M | $371.1M | ||
| Q1 25 | $134.3M | $371.1M | ||
| Q4 24 | $154.6M | — | ||
| Q3 24 | $102.6M | $440.8M | ||
| Q2 24 | $87.0M | $440.8M | ||
| Q1 24 | $49.5M | $440.8M |
| Q4 25 | $282.8M | — | ||
| Q3 25 | $284.6M | — | ||
| Q2 25 | $286.4M | — | ||
| Q1 25 | $288.2M | — | ||
| Q4 24 | $290.0M | — | ||
| Q3 24 | $287.3M | — | ||
| Q2 24 | $288.0M | — | ||
| Q1 24 | $288.8M | — |
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.5B | $382.3M | ||
| Q2 25 | $1.5B | $382.3M | ||
| Q1 25 | $1.5B | $382.3M | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.4B | $491.7M | ||
| Q2 24 | $1.4B | $491.7M | ||
| Q1 24 | $1.4B | $491.7M |
| Q4 25 | $2.2B | — | ||
| Q3 25 | $2.1B | $495.9M | ||
| Q2 25 | $2.1B | $495.9M | ||
| Q1 25 | $2.1B | $495.9M | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.1B | $601.9M | ||
| Q2 24 | $2.1B | $601.9M | ||
| Q1 24 | $2.1B | $601.9M |
| Q4 25 | 0.19× | — | ||
| Q3 25 | 0.19× | — | ||
| Q2 25 | 0.19× | — | ||
| Q1 25 | 0.20× | — | ||
| Q4 24 | 0.20× | — | ||
| Q3 24 | 0.20× | — | ||
| Q2 24 | 0.20× | — | ||
| Q1 24 | 0.20× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $57.6M | — |
| Free Cash FlowOCF − Capex | $46.6M | — |
| FCF MarginFCF / Revenue | 12.2% | — |
| Capex IntensityCapex / Revenue | 2.9% | — |
| Cash ConversionOCF / Net Profit | 4.93× | — |
| TTM Free Cash FlowTrailing 4 quarters | $110.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $57.6M | — | ||
| Q3 25 | $27.3M | — | ||
| Q2 25 | $64.4M | — | ||
| Q1 25 | $-3.1M | — | ||
| Q4 24 | $62.3M | — | ||
| Q3 24 | $22.7M | — | ||
| Q2 24 | $44.1M | — | ||
| Q1 24 | $-21.8M | — |
| Q4 25 | $46.6M | — | ||
| Q3 25 | $17.0M | — | ||
| Q2 25 | $56.6M | — | ||
| Q1 25 | $-10.3M | — | ||
| Q4 24 | $56.0M | — | ||
| Q3 24 | $17.7M | — | ||
| Q2 24 | $39.0M | — | ||
| Q1 24 | $-26.9M | — |
| Q4 25 | 12.2% | — | ||
| Q3 25 | 4.7% | — | ||
| Q2 25 | 16.4% | — | ||
| Q1 25 | -3.1% | — | ||
| Q4 24 | 17.2% | — | ||
| Q3 24 | 5.7% | — | ||
| Q2 24 | 12.5% | — | ||
| Q1 24 | -9.0% | — |
| Q4 25 | 2.9% | — | ||
| Q3 25 | 2.8% | — | ||
| Q2 25 | 2.2% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | 1.9% | — | ||
| Q3 24 | 1.6% | — | ||
| Q2 24 | 1.6% | — | ||
| Q1 24 | 1.7% | — |
| Q4 25 | 4.93× | — | ||
| Q3 25 | 25.34× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -4.36× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
